Cargando…
Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China
BACKGROUND: This study is to evaluate the safety of two kinds of PCV13 carriers by monitoring the occurrence of adverse event following immunization (AEFI) after the launch of two kinds of PCV13 carriers in Jiangsu Province, China. METHODS: The AEFI Information System (CNAEFIS) of mainland China was...
Autores principales: | Hu, Ran, Liu, Yuanbao, Zhang, Lei, Kang, Guodong, Xu, Borong, Li, Mingma, Yu, Jing, Zhu, Yuanyuan, Guo, Hongxiong, Wang, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613985/ https://www.ncbi.nlm.nih.gov/pubmed/37908689 http://dx.doi.org/10.3389/fpubh.2023.1272562 |
Ejemplares similares
-
Monomeric crystal structure of the vaccine carrier protein CRM(197) and implications for vaccine development
por: Gallagher, D. Travis, et al.
Publicado: (2023) -
The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015–2018
por: Hu, Ran, et al.
Publicado: (2021) -
Site‐Specific Multi‐Functionalization of the Carrier Protein CRM(197) by Disulfide Rebridging for Conjugate Vaccine Development
por: Trattnig, Nino, et al.
Publicado: (2022) -
Investigating the Deoxyribonuclease Activity of CRM197
with Site-Directed Mutagenesis
por: Bravo-Bautista, Nathalie, et al.
Publicado: (2019) -
Structural and immunological characterization of E. coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines
por: Mishra, Ravi P.N., et al.
Publicado: (2018)